8-K/A: Renovaro Inc. Completes Acquisition of Renovaro Cube, Files Amended 8-K with Audited Financials

Renovaro Inc. has finalized its acquisition of Renovaro Cube and filed an amended 8-K report including audited financials and pro forma statements.

Summary

• Renovaro Inc. acquired Renovaro Cube Intl Ltd on February 13, 2024, as detailed in an amended 8-K filing.
• The filing includes audited financial statements for Renovaro Cube for the years ended December 31, 2023 and 2022.
• Unaudited pro forma combined financial information is provided, reflecting the acquisition as if it occurred on July 1, 2022, for the statements of operations and July 1, 2023 for the balance sheet.
• The pro forma information includes the six months ended December 31, 2023, and the year ended June 30, 2023.
• Renovaro Cube's financial statements show a net loss of €2,100,579 for the period from August 24, 2023, to December 31, 2023, and a net loss of €623,982 for the year ended December 31, 2022.
• The acquisition was treated as an asset acquisition, with the majority of the value allocated to in-process research and development (IPR&D) which was expensed as incurred.
• Renovaro Cube had a cash balance of €114,520 as of December 31, 2023, and used €1,440,139 in cash from operating activities during the period from August 24, 2023 to December 31, 2023.
• The company has an accumulated deficit of €2,100,579 as of December 31, 2023, raising concerns about its ability to continue as a going concern.
• The pro forma combined balance sheet shows total assets of $217,433,447 and total liabilities of $49,606,286 as of December 31, 2023.
• The pro forma combined net loss was $(42,490,305) for the year ended June 30, 2023, and $(15,904,206) for the six months ended December 31, 2023.

Sentiment

Score: 3

Explanation: The document reveals significant financial challenges, including substantial losses, negative cash flow, and a going concern issue, which overshadow the positive aspect of the acquisition completion. The sentiment is therefore negative.

Positives

• The acquisition of Renovaro Cube by Renovaro Inc. has been completed.
• The filing provides audited financial statements for Renovaro Cube, offering transparency.
• Pro forma financial information gives investors a view of the combined entity's potential performance.
• The company has a research and development project focused on an AI platform designed for early cancer detection.

Negatives

• Renovaro Cube experienced a significant net loss of €2,100,579 for the period from August 24, 2023 to December 31, 2023.
• The company has an accumulated deficit of €2,100,579, raising substantial doubt about its ability to continue as a going concern.
• Renovaro Cube used €1,440,139 in cash from operating activities during the period from August 24, 2023 to December 31, 2023.
• The pro forma combined net loss was $(42,490,305) for the year ended June 30, 2023, and $(15,904,206) for the six months ended December 31, 2023.
• The acquisition was treated as an asset acquisition, with the majority of the value allocated to IPR&D which was expensed as incurred.

Risks

• Renovaro Cube's negative cash flows from operations and accumulated deficit raise substantial doubt about its ability to continue as a going concern.
• The company's future is dependent on obtaining necessary equity or debt financing and generating profit from sales and positive operating cash flows, which is not assured.
• The company is in the development stage and faces risks associated with a new and unproven business.
• The company's lack of a significant operating history makes it difficult to manage operations and predict future results.
• The final determination of any tax authority, upon examination of the company's tax returns, could have an adverse effect on the company's operating results and balance sheets.

Future Outlook

The company's future is dependent on obtaining necessary equity or debt financing to continue operations and ultimately generating profit from sales and positive operating cash flows, which is not assured.

Management Comments

• Management believes that significant uncertainty exists with respect to future realization of the deferred tax assets and has therefore established a full valuation allowance.
• Management concluded that the IPR&D AI project qualifies as an identifiable intangible asset within the context of a business combination and represents over 90% of the fair value of the assets acquired, therefore accounting for the acquisition as an asset acquisition.

Industry Context

The document highlights the acquisition of a company specializing in data science and data mining, with a focus on AI-powered precision medicine. This aligns with the broader industry trend of leveraging AI and big data in healthcare for early diagnosis and personalized treatments. The company aims to be disruptive in the industry with a broad range of cutting edge software, services, methods, and models to tackle big data challenges.

Comparison to Industry Standards

• The financial performance of Renovaro Cube, particularly the significant net losses and negative cash flow, is concerning when compared to established companies in the data science and AI-driven healthcare sectors.
• Companies like Tempus and Flatiron Health, which also focus on data-driven healthcare solutions, have demonstrated more robust revenue generation and financial stability, although they have also raised significant capital.
• The treatment of the acquisition as an asset acquisition, with the majority of the value allocated to IPR&D and expensed immediately, is not typical for established companies with revenue-generating assets.
• The going concern issue raised by the auditors is a significant red flag, indicating a higher level of risk compared to industry peers with more stable financial positions.

Legal Proceedings

• On March 14, 2024 Grace Systems as a defendant was served with a judgement by default by the District Court of North-Holland by Stumple Interrnational B.V. and De Projectinrichter B.V. as joint claimants.
• The Company filed a write of appeal to dismiss the judgement in March 2024.
• Grace Systems will bring the appeal before the High Court of Amsterdam, the Netherlands on April 30, 2024.

Related Party Transactions

• Due to related party balances consisted of short term loans from Imbott Group B.V., SEPA Beheer B.V. and C.K. van Kalken Beheer B.V., all of which are stockholders of the Successor, Renovaro Cube Intl Ltd and former stockholders of the Predecessor, Grace Bio Omics B.V., is an affiliated entity by way of mutual owners.
• The apartment lease was entered into for the use of the CEO of the Company.

Stakeholder Impact

• Shareholders face significant risk due to the company's financial instability and going concern issue.
• Employees may be concerned about job security given the company's financial challenges.
• Customers and suppliers may be hesitant to engage with the company due to its financial instability.
• Creditors face a higher risk of not being repaid due to the company's financial difficulties.

Next Steps

• The company needs to secure additional financing to continue operations.
• The company needs to generate revenue and positive operating cash flows.
• The company needs to address the going concern issue raised by the auditors.
• Grace Systems will bring an appeal before the High Court of Amsterdam, the Netherlands on April 30, 2024.

Key Dates

Keywords

acquisition, Renovaro Cube, financial statements, pro forma, net loss, going concern, asset acquisition, IPR&D, operating expenses, cash flow